Icon (NASDAQ:ICLR) Upgraded at Jefferies Financial Group

Icon (NASDAQ:ICLR) was upgraded by equities researchers at Jefferies Financial Group from a “hold” rating to a “strong-buy” rating in a research note issued to investors on Monday,Zacks.com reports.

A number of other equities research analysts have also recently commented on the company. Zacks Research upgraded Icon from a “strong sell” rating to a “hold” rating in a research note on Tuesday, November 25th. TD Cowen raised shares of Icon from a “hold” rating to a “buy” rating and lowered their price objective for the stock from $183.00 to $120.00 in a research report on Wednesday, February 18th. BMO Capital Markets reiterated a “market perform” rating and issued a $100.00 target price on shares of Icon in a research note on Thursday, February 12th. Barclays raised their price target on shares of Icon from $185.00 to $200.00 and gave the stock an “equal weight” rating in a research note on Monday, December 15th. Finally, Mizuho set a $216.00 price objective on Icon in a research note on Friday, January 9th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $157.47.

Icon Stock Performance

Shares of Icon stock opened at $104.66 on Monday. The business’s fifty day simple moving average is $165.34 and its 200 day simple moving average is $172.02. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.31. Icon has a 12 month low of $66.57 and a 12 month high of $211.00. The firm has a market capitalization of $8.45 billion, a P/E ratio of 14.16, a price-to-earnings-growth ratio of 2.47 and a beta of 1.27.

Institutional Investors Weigh In On Icon

Hedge funds and other institutional investors have recently bought and sold shares of the business. Private Trust Co. NA lifted its position in shares of Icon by 200.0% during the third quarter. Private Trust Co. NA now owns 141 shares of the medical research company’s stock worth $25,000 after acquiring an additional 94 shares in the last quarter. Toth Financial Advisory Corp bought a new stake in shares of Icon during the 4th quarter valued at $27,000. EFG International AG purchased a new stake in Icon during the 4th quarter worth about $27,000. Ameriflex Group Inc. bought a new position in Icon in the 3rd quarter worth about $33,000. Finally, Abound Financial LLC purchased a new position in Icon during the 4th quarter valued at about $54,000. Institutional investors own 95.61% of the company’s stock.

Icon Company Profile

Icon plc (NASDAQ: ICLR) is a global provider of outsourced drug development and clinical research services to the pharmaceutical, biotechnology and medical device industries. The company partners with clients at all stages of the product life cycle, offering expertise in protocol design, trial execution and regulatory compliance across a broad range of therapeutic areas.

Icon’s service portfolio encompasses clinical trial management, data management and biostatistics, medical imaging, pharmacovigilance and safety monitoring, laboratory sciences and specialized analytical solutions.